Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries

Journal of Nuclear Cardiology

Volumn 14, Issue 2, 2007, Pages 194-199

  Storto, Giovanni ^a,b   Pellegrino, Teresa ^c   Sorrentino, Anna Rita ^a   Luongo, Luca ^a   Petretta, Mario ^a   Cuocolo, Alberto ^a,b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Coronary flow reserve; single photon emission computed tomography imaging; type 2 diabetes mellitus

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY PRESSURE; DIABETIC PATIENT; DIAGNOSTIC VALUE; EXERCISE TEST; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULMONARY ARTERY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; BLOOD FLOW VELOCITY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIPYRIDAMOLE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RISK ASSESSMENT; TECHNETIUM TC 99M SESTAMIBI; VASODILATOR AGENTS;

EID: 33947434096     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.12.327     Document Type: Article

References (28)

1. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
2. Laakso M. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. The Finnish studies. Ann Intern Med 124 (1996) 127-130
3. Nitenberg A., Valensi P., Sachs R., Dalim M., Aptecar E., and Attali J.R. Impairment of coronary vascular reserve and Ach-induced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal ventricular systolic function. Diabetes 32 (1993) 1017-1023
4. Nahser P.J., Brown R.E., Oskarsson H., Winnifold M.D., and Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation 91 (1995) 635-640
5. Mintz G.S., Painter J.A., Pichard A.D., Kent K.M., Satler L.F., Popma J.J., et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 25 (1995) 1479-1485
6. Yarom R., Zirkin H., Stammler G., and Rose A.G. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material. J Pathol 166 (1992) 265-270
7. Meyer C., and Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus. Am J Cardiol 80 (1997) 94A-101A
8. Di Carli M.F., Janisse J., Grunberger G., and Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41 (2003) 1387-1393
9. Pitkanen O.P., Nuutila P., Raitakari O.T., Ronnemaa T., Koskinen P.J., Iida H., et al. Coronary flow reserve is reduced in young men with IDDM. Diabetes 47 (1998) 248-254
10. Srinivasan M., Herrero P., McGill J.B., Bennik J., Heere B., Lesniak D., et al. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol 46 (2005) 42-48
11. Nahser P.J., Brown R.E., Oskarsson H., Winniford M.D., and Rossen J.D. Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation 91 (1995) 635-640
12. Yokoyama I., Yonekura K., Ohtake T., Yang W., Shin W.S., Yamada N., et al. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease. J Nucl Med 41 (2000) 978-985
13. Bergmann S.R., Fox K.A., Rand A.L., McElvany K.D., Welch M.J., Markham J., et al. Quantification of regional myocardial blood flow in vivo with H2-15O. Circulation 70 (1984) 724-733
14. Araujo L.I., Lammertsma A.A., Rhodes C.G., McFalls E.O., Iida H., Rechavia E., et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 83 (1991) 875-885
15. Hutchins G., Schwaiger M., Rosenspire K.C., Krivokapitch J., Schelbert H.R., and Kuhl D.E. Noninvasive quantification of regional myocardial blood flow with N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15 (1990) 1032-1042
16. Schelbert H.R., Phelps M.E., Huang SC MacDonald N.S., Hansen H., Selin C., et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 63 (1981) 1259-1272
17. Sugihara H., Yonekura Y., Kataoka K., Fukai D., Kitamura N., and Taniguchi Y. Estimation of coronary flow reserve with the use of dynamic planar and SPECT images of Tc-99m tetrofosmin. J Nucl Cardiol 8 (2001) 575-579
18. Storto G., Cirillo P., Vicario M.L., Pellegrino T., Sorrentino A.R., Petretta M., et al. Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique. J Nucl Cardiol 11 (2004) 682-688
19. Devereux R.B., and Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55 (1977) 613-618
20. Vicario M.L., Cirillo L., Storto G., Pellegrino T., Ragone N., Fontanella L., et al. Influence of risk factors on coronary flow reserve in patients with 1-vessel coronary artery disease. J Nucl Med 46 (2005) 1438-1443
21. Acampa W., Spinelli L., Petretta M., De Lauro F., Ibello F., and Cuocolo A. Prognostic value of myocardial ischemia in patients with uncomplicated acute myocardial infarction: direct comparison of stress echocardiography and myocardial perfusion imaging. J Nucl Med 46 (2005) 417-423
22. Sundell J., Janatuinen T., Ronnemaa T., Raitakari O.T., Toikka J., Nuutila P., et al. Diabetic background retinopathy is associated with impaired coronary vasoreactivity in people with Type 1 diabetes. Diabetologia 47 (2004) 725-731
23. de Silva R., and Camici P.G. Role of positron emission tomography in the investigation of human coronary circulatory function. Cardiovasc Res 28 (1994) 1595-1612
24. Taki J., Fujino S., Nakajima K., Matsunari I., Okazaki H., Saga T., et al. Tc-99m sestamibi retention characteristics during pharmacological hyperemia in human myocardium: comparison with coronary flow reserve measured by Doppler flowire. J Nucl Med 42 (2001) 1457-1463
25. Ito Y., Katoh C., Noriyasu K., Kuge Y., Furuyama H., Morita K., et al. Estimation of myocardial blood flow and myocardial flow reserve by 99mTc-sestamibi imaging: comparison with the results of O-15 H2O PET. Eur J Nucl Med Mol Imaging 30 (2003) 281-287
26. Smits P., Williams S.B., Lipson D.E., Banitt P., Rongen G.A., and Creager M.A. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation 92 (1995) 2135-2141
27. Buus N.H., Bottcher M., Hermansen F., Sander M., Nielsen T.T., and Mulvany M.J. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104 (2001) 2305-2310
28. Czernin J., Porenta G., Brunken R., Krivokapich J., Chen K., Bennett R., et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88 (1993) 62-69